These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29179174)

  • 1. [Current advances and future prospects of genome editing technology in the field of biomedicine.].
    Sakuma T
    Clin Calcium; 2017; 27(12):1788-1793. PubMed ID: 29179174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas9 technology: applications and human disease modelling.
    Torres-Ruiz R; Rodriguez-Perales S
    Brief Funct Genomics; 2017 Jan; 16(1):4-12. PubMed ID: 27345434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The application of CRISPR/Cas9 genome editing technology in cancer research].
    Wang DY; Ma N; Hui Y; Gao X
    Yi Chuan; 2016 Jan; 38(1):1-8. PubMed ID: 26787518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Basics and applications of genome editing technology].
    Yamamoto T; Sakamoto N
    Rinsho Ketsueki; 2016; 57(10):1869-1873. PubMed ID: 27725582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genome editing ~Principle and possibility of a novel genetic engineering technology. Basic principles of genome editing.].
    Yamamoto T
    Clin Calcium; 2017; 27(11):1638-1644. PubMed ID: 29074838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current researches and prospects of human induced pluripotent stem cells and gene editing technology of CRISPR/Cas9 in inherited ocular diseases].
    Fan F; Wu JH; Luo Y
    Zhonghua Yan Ke Za Zhi; 2021 Sep; 57(9):712-716. PubMed ID: 34865411
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Ma X; Wong AS; Tam HY; Tsui SY; Chung DL; Feng B
    Zool Res; 2018 Mar; 39(2):58-71. PubMed ID: 29515088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From hacking the human genome to editing organs.
    Tobita T; Guzman-Lepe J; Collin de l'Hortet A
    Organogenesis; 2015; 11(4):173-82. PubMed ID: 26588350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development and challenges of gene editing technology].
    Liu Y; Xiong Y; Cai Z; Zhang B
    Sheng Wu Gong Cheng Xue Bao; 2019 Aug; 35(8):1401-1410. PubMed ID: 31441611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic applications of CRISPR RNA-guided genome editing.
    Koo T; Kim JS
    Brief Funct Genomics; 2017 Jan; 16(1):38-45. PubMed ID: 27562951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
    Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
    Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental history and application of CRISPR in human disease.
    Liang P; Zhang X; Chen Y; Huang J
    J Gene Med; 2017 Jun; 19(6-7):. PubMed ID: 28623876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and epigenetic editing in
nervous system
.
    Day JJ
    Dialogues Clin Neurosci; 2019 Dec; 21(4):359-368. PubMed ID: 31949403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer CRISPR Screens In Vivo.
    Chow RD; Chen S
    Trends Cancer; 2018 May; 4(5):349-358. PubMed ID: 29709259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Mediated Epigenome Editing.
    Enríquez P
    Yale J Biol Med; 2016 Dec; 89(4):471-486. PubMed ID: 28018139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of genome editing tools in precision medicine research.
    Li S; Yang YY; Qiu Y; Chen Y; Xu LW; Ding QR
    Yi Chuan; 2017 Mar; 39(3):177-188. PubMed ID: 28420614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.